Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. AMBI Enterprises LLC
WARNING LETTER
•AMBI Enterprises LLC•April 19, 2022

AMBI Enterprises LLC – FDA Warning Letter, Apr 19, 2022

Record Details

The FDA issued a Warning Letter to Mr. Lennarz on April 13, 2022, concerning the distribution of AMBI® SKINCARE Fade Cream OILY SKIN and AMBI® SKINCARE Fade Cream NORMAL SKIN. These products are intended for skin bleaching and contain Hydroquinone 2% as an active ingredient.

The FDA determined these products are unapproved new drugs and misbranded under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, they violate section 505(a) as unapproved new drugs and section 502(ee) as misbranded drugs. The products are deemed new drugs under section 201(p)(1) and subject to the requirement of an approved new drug application under section 505, effective September 23, 2020. No FDA-approved application exists for these products.

The FDA cited product labels and website claims (ambi.com) as evidence of intended use for skin bleaching, such as "Fades dark spots for even, natural skin tone" and "Skin Bleaching Agent." The agency previously determined in a 2006 proposed rule that OTC skin bleaching drug products, including those with hydroquinone, are not generally recognized as safe and effective (GRASE).

The letter requires prompt corrective action within 15 working days, including investigating and preventing recurrence of violations. Failure to comply may result in legal action, including seizure

Company
AMBI Enterprises LLC
Inspection date
April 19, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Carolyn E. Becker
View Company Profile

ID · 38b8eae3-057e-46df-bc0a-8cf0b61b8e11

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 352(ee)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 355h21 U.S.C. 355h(a)(4)21 U.S.C. 35521 CFR 201.12821 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AMBI Enterprises LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.